Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-01

FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride (XL) from Exelan Pharmaceuticals, authorizing continued marketing of the extended-release fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE)